Interested in Clinical Trials?

Contact Media Relations at media@tnfpharma.com.

TNF Pharmaceuticals® 
855 N Wolfe St, Ste 601
Baltimore, Maryland 21205
(813) 864-2566

Clinical Trials Contact

For patients or physicians interested in learning more about the studies, please visit clinicaltrials.gov

If you are interested in becoming a principal investigator for a future study please complete the form below.

  • We are committed to protecting your privacy and confidential information. All information you provide will be securely stored and will only be used to check if you pre-qualify for this study. No medical details will be retained, and your contact details will be forwarded to a study location only at your request. Please note that we cannot respond to medical questions regarding personal health information or accept private medical information.

    Please consult your healthcare provider with any questions regarding your medical condition or the medical condition of a family member.

  • This field is for validation purposes and should be left unchanged.

Subscribe to TNF Pharmaceuticals

Stay up-to-date on new developments, news and research at TNF Pharmaceuticals®

  • This field is for validation purposes and should be left unchanged.

Unsolicited Information Policy

Last updated on January 16 2021 Please do not send or provide any unsolicited confidential or proprietary submissions to TNF Pharmaceuticals, its employees, or contractors. The purpose of this unsolicited information policy is to avoid potential misunderstandings or disputes when TNF Pharmaceuticals’ products, product enhancements, services, service enhancements, clinical trials, strategies, content, etc might seem similar to unsolicited submissions provided to TNF Pharmaceuticals. For the avoidance of doubt, and with the informed consent provided by this warning, any unsolicited content submitted to TNF Pharmaceuticals may be deemed to be non-confidential and not proprietary, and it is understood that TNF Pharmaceuticals is free to use and redistribute such information on an unrestricted basis without any compensation to the sender.

Subscribe to receive TNF Pharmaceuticals announcements
  • This field is for validation purposes and should be left unchanged.